tiprankstipranks
Immunicum AB (SE:IMMU)
:IMMU
Sweden Market
IMMU
Immunicum AB
RESEARCH TOOLSreports

Immunicum AB (IMMU) Income Statement

3 Followers

Immunicum AB Income Statement

Last quarter (Q4 2025), Immunicum AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, Immunicum AB's net income was kr-41.08M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 28.49Mkr 3.00Mkr 6.00K
Gross Profit
kr 0.00kr -6.52Mkr 28.49Mkr -1.85Mkr -1.84M
Operating Expenses
kr 120.26Mkr 128.63Mkr 123.40Mkr 134.70Mkr 129.28M
Depreciation and Amortization
kr 0.00kr 6.52Mkr 3.37Mkr 4.85Mkr 1.85M
EBITDA
kr -120.26Mkr -120.66Mkr -97.85Mkr -128.67Mkr -128.28M
Operating Income
kr -120.26Mkr -135.15Mkr -100.65Mkr -133.68Mkr -130.10M
Other Income/Expenses
kr 7.00Mkr 6.75Mkr -969.00Kkr -5.10Mkr -3.31M
Pretax Income
kr -113.26Mkr -128.40Mkr -101.62Mkr -138.78Mkr -133.41M
Net Income
kr -113.26Mkr -128.40Mkr -101.62Mkr -136.99Mkr -136.69M
Per Share Metrics
Basic EPS
kr -2.17kr -2.64kr -4.40kr -0.63kr -0.68
Diluted EPS
kr -2.17kr -2.64kr -4.39kr -0.63kr -0.68
Weighted Average Shares Outstanding
 52.19M 48.64M 23.10M 216.49M 199.75M
Weighted Average Shares Outstanding (Diluted)
 52.19M 48.64M 23.13M 216.49M 199.75M
Currency in SEK

Immunicum AB Earnings and Revenue History